Microarrays first appeared on the scene around 1995, and it was not long before their use became quite widespread. Early analyses were modelled on those of the pioneers. By around 2000, however, ...

In microarray gene expression experiments, several diverse conditions in each experiment (e.g., time, doses, replicates) increase the data points from tens of thousands of measurements for a single ...

PHOENIX, August 16, 2004-5AM Solutions, a software solution provider enabling biomedical research, today announced the release of Microarray Enterprise Manager TM (MEM). The solution was delivered in ...

The study of microbial communities from environmental samples, known as metagenomics, has been propelled forward by technological advancements in high-throughput sequencing such as 454’s Genome ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

As a graduate student, Eric Olson learned something about DNA microarrays: Biochip data management can be vexing. His graduate adviser abandoned a number of microarray experiments because it was too ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...

Google isn’t the only company working on mapping out the entire world with satellite imagery and detailed information about every nook and cranny in the universe. Two companies are teaming up to ...

Expert Rev Mol Diagn. 2013;13(6):601-611. In other situations, normal microarray analysis in the presence of an abnormal karyotype, such as marker chromosomes, is reassuring, as it indicates that the ...

This study aims to identify potential biomarkers of hepatocellular carcinoma (HCC) occurrence/recurrence and obesity, along with the molecular mechanisms that involve these biomarkers. Three ...